首页> 外文期刊>BMC Infectious Diseases >Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China
【24h】

Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China

机译:中国上海上海肠道血清血管A71和Coxsackievirus A16引起的严重手动,脚和口病的临床特征及管理

获取原文
           

摘要

Hand, foot and mouth disease (HFMD) is a transmissible infectious disease caused by human enteroviruses (EV). Here, we described features of children with severe HFMD caused by EV-A71 or coxsackievirus A16 (CV-A16) in Shanghai, China. Severe EV-A71 or CV-A16 caused HFMD children admitted to the Xinhua Hospital from January 2014 and December 2016, were recruited retrospectively to the study. Symptoms and findings at the time of hospitalization, laboratory tests, treatments, length of stay and residual findings at discharge were systematically recorded and analyzed. Of 19,995 children visited clinic service with probable HFMD, 574 children (2.87%) were admitted, 234 children (40.76%) were confirmed with EV-A71 (90/574) or CV-A16 (144/574) disease. Most (91.02%) of the patients were under 5?years. Initial clinical symptoms of EV-A71 and CV-A16 cases were: fever ?39?°C in 81 (90%) and 119 (82.63%), vomiting in 31 (34.44%) and 28 (19.44%), myoclonic twitching in 19 (21.11%) and 11(7.64%), startle in 21 (23.33%) and 20 (13.69%), respectively. Serum levels of interleukin-1β (IL-1β), IL-2, IL-6, IL-8, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α) were significantly upregulated in severe HFMD subjects. Forty-seven children (20.08%) treated with intravenous gamma globulin (IVIG) showed decreased duration of illness episodes. All children were discharged without complications. EV-A71 and CV-A16 accounted 40.76% of admitted HFMD during 2014 to 2016 in Xinhua Hospital. IVIG appeared to be beneficial in shortening the duration of illness episodes of severe HFMD.
机译:手,脚和口腔疾病(HFMD)是由人肠病病毒(EV)引起的传染性传染病。在这里,我们描述了中国上海的EV-A71或Coxsackievirus A16(CV-A16)引起严重HFMD的儿童的特征。严重的EV-A71或CV-A16从2014年1月和2016年12月录取了新华医院的HFMD儿童,回顾性地招募了这项研究。系统地记录和分析了住院时间,实验室测试,治疗,住院时间长度和残留结果时的症状和发现。在19,995名儿童中访问了可能的HFMD,574名儿童(2.87%)被录取,234名儿童(40.76%)用EV-A71(90/574)或CV-A16(144/574)疾病确认。大多数(91.02%)的患者未满5岁。 EV-A71和CV-A16病例的初始临床症状是:发烧>?39?°C在81(90%)和119(82.63%)中,呕吐31(34.44%)和28(19.44%),肌阵挛抽搐在19(21.11%)和11(7.64%)中,分别为21(23.33%)和20(13.69%)的惊吓。在严重的HFMD受试者中显着上调了血清白细胞介素-1β(IL-1β),IL-2,IL-6,IL-8,干扰素-γ(IFN-γ),肿瘤坏死因子-α(TNF-α) 。用静脉γ球蛋白(IVIG)治疗的四十七个儿童(20.08%)显示出疾病持续时间降低。所有儿童都没有并发症出院。 EV-A71和CV-A16占2014年至2016年入院HFMD的40.76%,于2016年在新华医院。 Ivig似乎有利于缩短严重HFMD的疾病发作的持续时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号